Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.29M Sell
41,500
-5,700
-12% -$309K 0.04% 175
2025
Q4
$2.31M Sell
47,200
-3,000
-6% -$140K 0.04% 152
2025
Q3
$2.17M Hold
50,200
0.04% 155
2025
Q2
$1.93M Hold
50,200
0.04% 152
2025
Q1
$1.94M Buy
50,200
+1,100
+2% +$40.3K 0.06% 129
2024
Q4
$1.66M Hold
49,100
0.06% 128
2024
Q3
$2.01M Buy
+49,100
New +$2.01M 0.07% 122

Other funds holding GSK

Harvest Portfolios Group's GSK Position: Q1 2026 in Review

Harvest Portfolios Group reduced its GSK (GSK) stake by 12% in Q1 2026, selling an estimated $309K and leaving 41,500 shares worth $2.29M. The position accounts for 0.04% of the portfolio, ranked #175.

Harvest Portfolios Group first reported a position in GSK in Q3 2024 and has held it in 7 quarters since. The position peaked at $2.31M in Q4 2025. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Harvest Portfolios Group held 41,500 shares of GSK worth $2.29M as of Q1 2026.
  • Harvest Portfolios Group sold 5,700 GSK shares in Q1 2026, an estimated $309K.
  • GSK made up 0.04% of Harvest Portfolios Group's portfolio in Q1 2026, its #175 holding.
  • Harvest Portfolios Group first reported a position in GSK in Q3 2024 and has held it in 7 quarters since.
  • Harvest Portfolios Group's GSK position peaked at $2.31M in Q4 2025.
  • 1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Harvest Portfolios Group's 13F filing for Q1 2026, filed 14 May 2026.